Evidence map›Paper›PMID 41732618›Full record

ArticleCureus2026

Simultaneous Diagnosis of Myasthenia Gravis and Neurosyphilis, With Symptoms Improving After Neurosyphilis Treatment: A Case Report.

Juan Fernando Ortiz, Nicholas J Lannen, Maria Daniela Peralta, Camila D Lopez

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Juan Fernando OrtizNeurology, Corewell Health Medical Group, Grand Rapids, USA.
Nicholas J LannenNeurology, Corewell Health, Grand Rapids, USA.
Maria Daniela PeraltaMedicine, Universidad de Cuenca, Cuenca, ECU.
Camila D LopezMedicine, Universidad San Francisco de Quito, Quito, ECU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Simultaneous diagnosis of myasthenia gravis (MG) and early asymptomatic neurosyphilis is extremely rare. There have only been two cases described in the literature. To the best of our knowledge, this was the first case of MG resolving with concurrent treatment of neurosyphilis. Our patient was a 67-year-old male who presented to the hospital with a diffuse rash, bilateral ptosis, bilateral facial weakness, and bulbar symptoms (dysarthria, difficulty with mastication, and difficulty drinking fluids).  After testing positive for syphilis in serum and cerebrospinal fluid (CSF), the patient was diagnosed with neurosyphilis. Thus, it was suspected that his neurological findings were manifestations of early symptomatic neurosyphilis. The patient was treated with intravenous penicillin G for one week, and later, it was switched to intravenous ceftriaxone for two weeks due to cost and convenience. All symptoms resolved after three to four weeks. After being discharged, the patient tested positive for acetylcholine receptor antibodies. Subsequently, the patient underwent an electromyogram (EMG), which revealed a decremental response, confirming a diagnosis of MG. Infections are known to trigger autoimmune diseases and can lead to the development of new-onset MG. Neurosyphilis is relatively highly associated with other central nervous system (CNS) antibodies and can trigger other neurological disorders. Recognizing the differences in presentation and performing an accurate and comprehensive neurological exam can help differentiate early symptomatic neurosyphilis from neuromuscular disorders such as MG.

Indexed as

bulbar weakenessdysarthrialate neurosyphilismyasthenia gravissingle nerve fiber

Identifiers

PMID41732618
PMCPMC12925367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.